LP
CTMX icon

LMR Partners’s CytomX Therapeutics CTMX Stock Holding History

LMR Partners’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Buy
+234,931
New +$1.19M 0.01% 964
2024
Q3 		– Sell
-15,046
Closed -$18.4K – 1369
2024
Q2 		$18.4K Sell
15,046
-3,200
-18% -$6.37K ﹤0.01% 984
2024
Q1 		$39.8K Buy
+18,246
New +$33.7K ﹤0.01% 1000
2022
Q4 		– Sell
-23,134
Closed -$34K – 1141
2022
Q3 		$34K Hold
23,134
– – ﹤0.01% 1130
2022
Q2 		$42K Buy
+23,134
New +$44.3K ﹤0.01% 1174

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return